Search Results - "ANDRE OLAUSSEN, Ken"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Are RAS mutations predictive markers of resistance to standard chemotherapy? by Soria, Jean-Charles, Loriot, Yohann, Mordant, Pierre, Deutsch, Eric, Olaussen, Ken André

    Published in Nature reviews. Clinical oncology (01-09-2009)
    “…KRAS mutations can be predictive of resistance to anti-EGFR monoclonal-based therapy in patients with colorectal cancer. Only limited studies, however, have…”
    Get full text
    Journal Article
  5. 5

    PARP inhibitors: an interesting pathway also for non-small cell lung cancer? by Levra, Matteo Giaj, Olaussen, Ken Andre, Novello, Silvia, Soria, Jean-Charles

    Published in Current pharmaceutical design (01-01-2014)
    “…Treatment of lung cancer is improving, also based on the identification of molecular characteristics of the tumor, of which some already constitute promising…”
    Get more information
    Journal Article
  6. 6

    A new step ahead for the consideration of ERCC1 as a candidate biomarker to select NSCLC patients for the treatment of cetuximab in combination with cisplatin by Olaussen, Ken André

    Published in Cancer biology & therapy (15-10-2009)
    “…Commentary to: The overexpression of ERCC-1 is involved in the resistance of lung cancer cells to cetuximab combined with DDP Jing-Jing Li, Ya Ding, Dan-Dan…”
    Get full text
    Journal Article
  7. 7

    Prognostic value of LIPC in non-small cell lung carcinoma by Galluzzi, Lorenzo, Goubar, Aicha, Olaussen, Ken, Vitale, Ilio, Senovilla, Laura, Michels, Judith, Robin, Angélique, Dorvault, Nicolas, Besse, Benjamin, Validire, Pierre, fouret, Pierre, Behrens, Carmen, Wistuba, Ignacio, Soria, Jean-Charles, Kroemer, Guido

    Published in Cell cycle (Georgetown, Tex.) (15-02-2013)
    “…Non-small cell lung carcinoma (NSCLC) is the most common form of lung cancer and is associated with a high mortality rate worldwide. The majority of…”
    Get full text
    Journal Article
  8. 8

    The "Guardian of the Genome"-An Old Key to Unlock the ERCC1 Issue by Friboulet, Luc, Soria, Jean-Charles, Olaussen, Ken André

    Published in Clinical cancer research (15-04-2019)
    “…Excision Repair Cross-Complementation Group 1 (ERCC1) participates in the repair of DNA intrastrand adducts (ISA) and interstrand cross-links, but its role as…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Telomere length, telomeric proteins and genomic instability during the multistep carcinogenic process by Raynaud, Christophe Michel, Sabatier, Laure, Philipot, Ophelie, Olaussen, Ken André, Soria, Jean-Charles

    Published in Critical reviews in oncology/hematology (01-05-2008)
    “…Abstract Telomeres form specialized structures at the ends of eukaryotic chromosomes, preventing them from being wrongly recognized as DNA damage. The human…”
    Get full text
    Journal Article
  14. 14

    ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ Analysis by Bepler, Gerold, Olaussen, Ken André, Vataire, Anne-Lise, Soria, Jean-Charles, Zheng, Zhong, Dunant, Ariane, Pignon, Jean-Pierre, Schell, Michael J, Fouret, Pierre, Pirker, Robert, Filipits, Martin, Brambilla, Elisabeth

    Published in The American journal of pathology (2011)
    “…The excision repair cross completing group 1 gene product (ERCC1) and the regulatory subunit of ribonucleotide reductase (RRM1) have been reported as being…”
    Get full text
    Journal Article
  15. 15
  16. 16

    No evidence for viral sequences in five lepidic adenocarcinomas (former "BAC") by a high-throughput sequencing approach by Berthet, Nicolas, Frangeul, Lionel, Olaussen, Ken André, Brambilla, Elisabeth, Dorvault, Nicolas, Girard, Philippe, Validire, Pierre, Fadel, Elie, Bouchier, Christiane, Gessain, Antoine, Soria, Jean-Charles

    Published in BMC research notes (15-12-2015)
    “…The hypothesis of an infectious etiology of the formerly named bronchiolo-alveolar carcinoma (BAC) has raised controversy. We investigated tumor lung tissues…”
    Get full text
    Journal Article
  17. 17

    Expression of Chemokine Receptor CCR6 as a Molecular Determinant of Adrenal Metastatic Relapse in Patients With Primary Lung Cancer by Raynaud, Christophe M, Mercier, Olaf, Dartevelle, Philippe, Commo, Frédéric, Olaussen, Ken André, de Montpreville, Vincent, André, Fabrice, Sabatier, Laure, Sorial, Jean-Charles

    Published in Clinical lung cancer (01-05-2010)
    “…Abstract Background Recent studies suggest that chemokines are involved in organ-specific metastatic relapse. We evaluated the potential implications of…”
    Get full text
    Journal Article
  18. 18

    DNA repair pathways and non-small cell lung cancer: clinical perspectives by Olaussen, Ken André, Planchard, David, Adam, Julien, Soria, Jean-Charles

    Published in Bulletin du cancer (01-03-2011)
    “…The role of DNA repair pathways is to maintain cellular integrity. However, genetic instability is a driving force in the development of tumor cells and many…”
    Get more information
    Journal Article
  19. 19

    Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer by Galluzzi, Lorenzo, Vitale, Ilio, Senovilla, Laura, Olaussen, Ken André, Pinna, Guillaume, Eisenberg, Tobias, Goubar, Aïcha, Martins, Isabelle, Michels, Judith, Kratassiouk, Gueorgui, Carmona-Gutierrez, Didac, Scoazec, Marie, Vacchelli, Erika, Schlemmer, Frederic, Kepp, Oliver, Shen, Shensi, Tailler, Maximilien, Niso-Santano, Mireia, Morselli, Eugenia, Criollo, Alfredo, Adjemian, Sandy, Jemaà, Mohamed, Chaba, Kariman, Pailleret, Claire, Michaud, Mickaël, Pietrocola, Federico, Tajeddine, Nicolas, de La Motte Rouge, Thibault, Araujo, Natalia, Morozova, Nadya, Robert, Thomas, Ripoche, Hugues, Commo, Frederic, Besse, Benjamin, Validire, Pierre, Fouret, Pierre, Robin, Angélique, Dorvault, Nicolas, Girard, Philippe, Gouy, Sébastien, Pautier, Patricia, Jägemann, Nora, Nickel, Ann-Christin, Marsili, Sabrina, Paccard, Caroline, Servant, Nicolas, Hupé, Philippe, Behrens, Carmen, Behnam-Motlagh, Parviz, Kohno, Kimitoshi, Cremer, Isabelle, Damotte, Diane, Alifano, Marco, Midttun, Øivind, Ueland, Per Magne, Lazar, Vladimir, Dessen, Philippe, Zischka, Hans, Chatelut, Etienne, Castedo, Maria, Madeo, Frank, Barillot, Emmanuel, Thomale, Juergen, Wistuba, Ignacio Ivan, Sautès-Fridman, Catherine, Zitvogel, Laurence, Soria, Jean-Charles, Harel-Bellan, Annick, Kroemer, Guido

    Published in Cell reports (Cambridge) (30-08-2012)
    “…Patients with non-small cell lung cancer (NSCLC) are routinely treated with cytotoxic agents such as cisplatin. Through a genome-wide siRNA-based screen, we…”
    Get full text
    Journal Article
  20. 20